Sign in

NCT03430609Active, not recruiting

Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma

Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma: A Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 22 Jul 2020

Brief summary (registry, in English)

Background: Endometriosis is defined by the presence of endometrial tissue outside the uterine cavity due to causes not yet fully elucidated. The disease affects approximately 2% of women of reproductive age and is associated with infertility. Approximately 17% to 44% of women with endometriosis exhibit endometrioma, or ovarian endometriosis. Laparoscopic cystectomy is currently considered the gold standard treatment for this problem, resulting in improvement of symptoms, a lower recurrence rate and a higher pregnancy rate among infertile patients. However, several studies have shown that this treatment is not free from risks because it is associated with reduction of the ovarian reserve due to accidental removal of ovarian cortex during stripping of the capsule or damage caused by the coagulation energy during hemostasis, even when performed by experienced surgeons. There is still controversy in the literature as to the cause of the reduction of the ovarian reserve, as the mere presence of endometrioma reduces ovarian function by itself. The aim of this study is to compare the effects of different hemostatic methods on the ovarian function of women subjected to laparoscopic surgery for ovarian endometrioma. Methods: Open-label randomized clinical trial to be conducted at Lauro Wanderley University Hospital from September 2017 to August 2020. Eighty-four patients will be randomly allocated to three groups according to the hemostatic technique used during laparoscopic surgery for ovarian endometrioma: bipolar coagulation, laparoscopic suture and hemostatic matrix. Ovarian function will be assessed by measuring serum anti-Mullerian hormone and follicle-stimulating hormone levels and by ultrasound antral follicle counts before surgery and 1, 3 and 6 months after surgery. The study was approved by the research ethics committee at the Medical Sciences Center, Federal University of Paraíba CAAE no. 71621717.9.0000.8069. Discussion: The present study intends to assess the ovarian function of patients with endometrioma subjected to laparoscopic surgical treatment, comparing different hemostatic techniques like bipolar coagulation versus suture versus hemostatic matrix with objective assessments of bipolar coagulation to avoid bias. Thus, the investigators expect to contribute data likely to dispel doubts on the subject.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
38 (actual)
First submitted
31 Oct 2017
Start date
1 Apr 2018
Primary completion date
1 Jul 2020
Lead sponsor
Faculdade de Ciências Médicas da Santa Casa de São Paulo
NCT number
NCT03430609

What you commit to

  • Study type: Interventional
  • Participants enrolled: 38
  • From 1 Apr 2018 to the primary completion date, 1 Jul 2020
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous ovarian surgery.

Other illness

  • Endocrine dysfunction (diabetes, thyroid disorders, hyperprolactinemia, adrenal disease, polycystic ovary syndrome).
  • Suspected ovarian malignant tumor requiring oophorectomy.
  • History of chemotherapy or radiotherapy.
  • Coagulation disorders.
  • Autoimmune disease.

Other

  • Use of hormones in the past 3 months.
  • Pregnancy.

Who the study is looking for

  • Age \> 18
  • Regular menstrual cycle (21 to 35 days).
  • Unilateral ovarian cyst suggestive of endometrioma.
  • Endometrioma and indication of laparoscopic surgery for cyst removal due to pelvic pain, infertility or cyst persistence.

Age in the registry: 18 years to 43 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidade Federal da Paraíba
Coordinator of this site? Confirm its status
João PessoaBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.